Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (NQ:KNSA)

42.52 -0.02 (-0.05%)

Official Closing Price Updated: 1:15 PM EST, Nov 28, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	147,753
Open	42.50
Bid (Size)	41.29 (100)
Ask (Size)	42.70 (1,000)
Prev. Close	42.54
Today's Range	42.02 - 42.89
52wk Range	17.82 - 42.98
Shares Outstanding	71,726,685
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Combines Technical Strength and Fundamental Growth Momentum ↗

November 20, 2025

KNSA stock shows strong technical momentum per the Minervini Trend Template and impressive fundamental growth with 421% EPS growth.

Via Chartmill

Performance

YTD	+113.2%	+113.2%
1 Month	+7.8%	+7.8%
3 Month	+26.9%	+26.9%
6 Month	+56.4%	+56.4%
1 Year	+90.5%	+90.5%

More News

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

What to Expect from Kiniksa Pharmaceuticals's Earnings ↗

October 27, 2025

Via Benzinga

5 Analysts Have This To Say About Kiniksa Pharmaceuticals ↗

October 17, 2025

Via Benzinga

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Identified by High Growth Momentum and Minervini Trend Screen ↗

October 08, 2025

Via Chartmill

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Earnings Preview: Kiniksa Pharmaceuticals ↗

July 28, 2025

Via Benzinga

What Analysts Are Saying About Kiniksa Pharmaceuticals Stock ↗

September 29, 2025

Via Benzinga

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗

September 24, 2025

Via Chartmill

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity ↗

September 22, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate ↗

September 01, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential ↗

August 25, 2025

Via Chartmill

KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout ↗

August 22, 2025

Via Chartmill

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗

August 08, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Aligns with Minervini’s Trend Model as a Strong Momentum Pick ↗

August 05, 2025

Via Chartmill

Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

August 04, 2025

Via Benzinga

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗

August 04, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 25, 2025

Via Benzinga

Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth ↗

July 02, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 05, 2025

Via Benzinga

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Via Benzinga

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

April 30, 2025

From Kiniksa Pharmaceuticals, Ltd.

Via GlobeNewswire

These stocks are gapping in today's session ↗

April 29, 2025

Via Chartmill

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday ↗

April 29, 2025

Via Benzinga

Frequently Asked Questions

Is Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares publicly traded?

Yes, Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is publicly traded.

What exchange does Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trade on?

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?

The ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market

What is the current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?

The current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 42.52

When was Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares last traded?

The last trade of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares was at 11/28/25 01:15 PM ET

What is the market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?

The market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 3.05B

How many shares of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares are outstanding?

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.